Diabetes Continuing Medical Education

Episodes 1-5 of 5

• • 

    

    Ruth S. Weinstock, MD, PhD

    Peer

  • 

    

    Susan B. Bressler, MD

    Peer

  • 

    

    Mark Dunbar, OD, FAAO

    Peer

  9

  

  RestartResume

  Saving Sight: What You Might Be Missing in Your Patients with Diabetes

  Saving Sight: What You Might Be Missing in Your Patients with Diabetes

  0.25 credits

• • 

    

    Eugene E. Wright, Jr., MD

    Peer

  • 

    

    Jolanta Małyszko, MD, PhD

    Peer

  • 

    

    María José Soler, MD, PhD

    Peer

  7

  

  RestartResume

  Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D

  Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D

  0.25 credits

• • 

    

    Jayanth Sridhar, MD

    Peer

  • 

    

    Avni P. Finn, MD, MBA

    Peer

  1

  

  RestartResume

  New Perspectives on Managing DR: Applying the Latest Strategies Into Clinical Practice

  New Perspectives on Managing DR: Applying the Latest Strategies Into Clinical Practice

  0.25 credits

• • 

    

    Robert J. Chilton, DO

    Peer

  • 

    

    John R. Nelson, MD, FACC, FNLA, FASNC

    Peer

  7

  

  RestartResume

  Clinicians' Update on Omega-3s in ASCVD Risk Reduction  

  Clinicians' Update on Omega-3s in ASCVD Risk Reduction  

  1.00 credits

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Andrea Steck, MD

    Peer

  • 

    

    Anette Gabriele Ziegler, MD

    Peer

  4

  

  RestartResume

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  0.50 credits